Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05035160 · ClinicalTrials.gov registry record

UCLA Perinatal Biospecimen Repository

A clinical trial of Pregnancy and High Risk Pregnancy, sponsored by Yalda Afshar, MD, PhD.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT05035160: Recruiting study of Pregnancy and High Risk Pregnancy, sponsored by Yalda Afshar, MD, PhD.

NCT05035160 is a study of Pregnancy and High Risk Pregnancy that is actively recruiting participants, run by Yalda Afshar, MD, PhD. The registered enrollment target is 1,000 participants, above the 867-participant average among 191 other Pregnancy trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05035160, a study of Pregnancy and High Risk Pregnancy, is actively recruiting participants, sponsored by Yalda Afshar, MD, PhD.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this investigator-initiated prospective observational cohort study is to establish the new UCLA Perinatal Biospecimen Repository (Perinatal Repository) for collection, storage, and distribution of the human data and biospecimens of the participants with perinatal pathology. The secure and shared high-quality resource of clinical data and biological specimens (Repository Materials), across pregnancy pathology related to research protocols at the Afshar's Lab will be created. Core variables of interest include clinical characteristics and relevant biological samples. Intention to collect perinatal data is aiding the efficiency and effectiveness of de-identified biorepository for pregnancy-at-risk outcome research. The primary aims of the project are: * To design the Case Report Forms (CRFs) for the clinical and biospecimen data. * To create and update the project-specific policies, agreements, and Standard Operating Procedures (SOPs). * To develop the data management system to assure personal health information de-identification, data integrity, participants welfare, and protocol compliance. * To develop and implement a quality management system for the Repository. * To collect and record in the Repository protocol-related clinical information. * To organize a consistent system to bank high-quality biospecimens while protecting participant-donor safety and privacy. * To establish the policies and procedures for Repository Materials dissemination and research collaboration. * To analyze the scientific results of the Repository creation. The secondary aim of the study is to provide a mechanism to store and share for research purposes the de-identified biospecimen and information about participants at risk for adverse pregnancy outcomes.

Primary Outcome

To establish the Perinatal Repository for collection, storage, and distribution of the human data and biospecimens of the participants with perinatal pathology

Conditions Studied

Pregnancy High Risk Pregnancy

Study Locations (1)

California

  • Afshar Lab, Department of Obstetrics & Gynecology, UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2021-07-30
Est. Completion 2028-12-31
Yalda Afshar, MD, PhD

1 total trials

What NCT05035160 shows while recruiting

NCT05035160 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 867-participant average among 191 other Pregnancy trials with a reported enrollment target (15% higher).

The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.

NCT05035160 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05035160 about?

NCT05035160 is a clinical study titled "UCLA Perinatal Biospecimen Repository". The purpose of this investigator-initiated prospective observational cohort study is to establish the new UCLA Perinatal Biospecimen Repository (Perinatal Repository) for collection, storage, and distribution of the human data and biospecimens of the participants with perinatal pathology. The secure...

What is the current status of trial NCT05035160?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2021-07-30. Estimated completion is 2028-12-31.

What conditions does trial NCT05035160 study?

This clinical trial studies the following conditions: Pregnancy, High Risk Pregnancy.

Who is sponsoring clinical trial NCT05035160?

This trial is sponsored by Yalda Afshar, MD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05035160 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05035160's enrollment target sits among peer trials

1,000 27th of 191 higher than 164 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05035160

Source: ClinicalTrials.gov NCT05035160, the US trial registry maintained by the National Library of Medicine. NCT05035160 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.